Serotonin Uptake Inhibitors
"Serotonin Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
| Descriptor ID |
D017367
|
| MeSH Number(s) |
D27.505.519.562.437.850 D27.505.519.625.600.850 D27.505.519.625.850.900 D27.505.696.577.600.850 D27.505.696.577.850.900
|
| Concept/Terms |
Serotonin Uptake Inhibitors- Serotonin Uptake Inhibitors
- 5-Hydroxytryptamine Uptake Inhibitors
- 5 Hydroxytryptamine Uptake Inhibitors
- Inhibitors, 5-HT Uptake
- Inhibitors, 5 HT Uptake
- Inhibitors, 5-Hydroxytryptamine Uptake
- Inhibitors, 5 Hydroxytryptamine Uptake
- Inhibitors, Serotonin Reuptake
- Reuptake Inhibitors, Serotonin
- Serotonin Reuptake Inhibitors
- Uptake Inhibitors, 5-HT
- Uptake Inhibitors, 5 HT
- Uptake Inhibitors, 5-Hydroxytryptamine
- Uptake Inhibitors, 5 Hydroxytryptamine
- Uptake Inhibitors, Serotonin
- 5-HT Uptake Inhibitors
- 5 HT Uptake Inhibitors
- Inhibitors, Serotonin Uptake
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Uptake Inhibitors".
This graph shows the total number of publications written about "Serotonin Uptake Inhibitors" by people in this website by year, and whether "Serotonin Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin Uptake Inhibitors" by people in Profiles.
-
Which SSRI is safest for patients with CVD and major depressive disorder? JAAPA. 2021 Apr 01; 34(4):18-19.
-
Association of first-line antidepressants and incident adverse metabolic effects. Can Fam Physician. 2020 12; 66(12):898-900.
-
Clopidogrel use and smoking cessation result in lower coated-platelet levels after stroke. Platelets. 2020; 31(2):236-241.
-
Case Report: Persistent Genital Arousal Disorder in an Adolescent Woman. J Pediatr Adolesc Gynecol. 2019 Apr; 32(2):186-188.
-
Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women. J Okla State Med Assoc. 2017 May; 110(5):272-274.
-
Sertraline-induced ventricular tachycardia. Am J Ther. 2013 Nov-Dec; 20(6):e720-2.
-
Clinical features and treatment responses in pediatric lymphocytic and collagenous colitis. J Pediatr Gastroenterol Nutr. 2013 Nov; 57(5):557-61.
-
Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims. J Anal Toxicol. 2013 May; 37(4):208-16.
-
Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertraline. J Neurol Neurosurg Psychiatry. 2009 Dec; 80(12):1416-7.
-
The cost-effectiveness of sertraline in the treatment of depression. Expert Opin Pharmacother. 2008 Oct; 9(14):2497-508.